These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 8510322

  • 1. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T, Tsuda S, Misawa S, Horiike S, Kuzuyama Y, Hirakawa K, Nakai H, Seriu T, Tanaka S, Nishida K.
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [Abstract] [Full Text] [Related]

  • 2. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T, Tamura K, Okamoto K, Kawada E, Murayama K, Maehara T, Sadakata H, Tamura J, Sawamura M, Morita K.
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 4. [A combined consecutive therapy with fosfomycin and sulbactam/cefoperazone for bacterial infections associated with hematological diseases].
    Misawa S, Tsuda S, Taniwaki M, Horiike S, Ariyama Y, Hirakawa K, Ueda Y, Kaneko H, Nakao M, Kashima K.
    Jpn J Antibiot; 1995 Apr; 48(4):514-21. PubMed ID: 7540219
    [Abstract] [Full Text] [Related]

  • 5. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Kitamura K, Takaku F, Miyazaki T, Miura, Mizoguchi H, Saito H, Masaoka T, Kimura I, Niho Y.
    Jpn J Antibiot; 1991 Sep; 44(9):979-86. PubMed ID: 1960859
    [Abstract] [Full Text] [Related]

  • 6. [Treatment with sulbactam/cefoperazone of severe infections in patients with hematological disorders].
    Ohno R, Hotta T, Ogura M, Ohnishi K, Morishita T, Murate T, Okumura M, Tanimoto M, Inoue C, Hamaguchi M.
    Jpn J Antibiot; 1989 Aug; 42(8):1713-9. PubMed ID: 2810734
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections].
    Sukoh M, Inoue T, Morita Y, Ito K, Togano Y, Yamanaka K, Hirose S, Takahashi T, Mita S, Mano K.
    Jpn J Antibiot; 1994 Feb; 47(2):170-80. PubMed ID: 8151910
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of sulbactam/cefoperazone for the treatment of infections in patients with hematologic diseases.
    Horiuchi A, Hasegawa H, Kageyama T, Yonezawa T, Kitani T, Masaoka T, Yasunaga K, Kawagoe H, Nagai K.
    Diagn Microbiol Infect Dis; 1989 Feb; 12(4 Suppl):215S-219S. PubMed ID: 2686922
    [Abstract] [Full Text] [Related]

  • 9. [Clinical experience with chemotherapy using sulbactam/cefoperazone for severe infections accompanying malignant hematological disorders].
    Fujii Y, Ayame H, Inoue H, Fujita N, Miyoshi K, Murano K, Hatao K, Yaga K, Kaku K, Kaneko T.
    Jpn J Antibiot; 1990 Jun; 43(6):1143-51. PubMed ID: 2232145
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of sulbactam/cefoperazone for severe infections associated with hematological disorders].
    Toyama K, Torii Y, Aoki I, Kikuchi M, Wakasugi K.
    Jpn J Antibiot; 1992 Aug; 45(8):1003-8. PubMed ID: 1433888
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of sulbactam/cefoperazone for infections during the chemotherapy of hematologic malignancy].
    Kawai Y, Ueda T, Iwasaki H, Nakamura T.
    Jpn J Antibiot; 1994 Sep; 47(9):1196-201. PubMed ID: 7990260
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S, Tsuda S, Nakagawa H, Nishigaki H, Okuda T, Taniwaki M, Misawa S, Takino T, Abe T.
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [Abstract] [Full Text] [Related]

  • 15. [Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ].
    Kitamura K, Hirai H, Hosoya N, Sugai M, Karasawa M, Naruse T, Miura Y, Ohmine K, Takagi S, Hirashima K, Bessho M, Fukuda M, Kawai N, Dan K, Ann E, Hoshino T, Oshimi K, Noguchi M, Egashira M, Ikeda Y, Kizaki M, Toyama K, Miyazawa K, Nagasu M, Hirasawa A.
    Kansenshogaku Zasshi; 1998 Jul; 72(7):761-70. PubMed ID: 9745228
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H, Yamao H, Saito H, Ohno R, Hotta T, Ohnishi K, Murate T, Kagami Y, Mitomo Y, Nitta M.
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
    Fukuda M, Endo K, Takinami S, Kawai N, Tominaga K, Maesaki S, Bessho M, Yamazaki T.
    Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
    [Abstract] [Full Text] [Related]

  • 20. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    Fukuda M, Kobayashi Y, Endo K, Kawai N, Tominaga K, Bessho M, Hirashima K.
    Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.